Patents by Inventor Meiqing Tu

Meiqing Tu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liposome formulation for delivery of Wnt signal pathway inhibitor
    Patent number: 10702473
    Abstract: A liposome formulation for delivery of Wnt signal pathway inhibitor is provided herein, which comprises lipid molecules and Wnt signal pathway inhibitor, wherein the liposome formulation is prepared through following steps: (1) providing an aqueous solution of the Wnt signal pathway inhibitor and providing an alcoholic solution of the lipid molecules, (2) mixing the aqueous solution of the Wnt signal pathway inhibitor and the alcoholic solution of the lipid molecules, (3) removing alcohol solvent to obtain the liposome formulation with Wnt signal pathway inhibitor encapsulated therein.
    Type: Grant
    Filed: April 3, 2018
    Date of Patent: July 7, 2020
    Assignee: Curegenix, Inc.
    Inventors: Yuhong Xu, Meiqing Tu, Xiaojing Chen
  • LIPOSOME FORMULATION FOR DELIVERY OF WNT SIGNAL PATHWAY INHIBITOR AND A METHOD FOR PREPARING THE SAME
    Publication number: 20190022002
    Abstract: A liposome formulation for delivery of Wnt signal pathway inhibitor is provided herein, which comprises lipid molecules and Wnt signal pathway inhibitor, wherein Wnt signal pathway inhibitor encapsulated within the liposome formulation has a concentration ranging from 0.07 mg/ml to 0.5 mg/ml.
    Type: Application
    Filed: April 3, 2018
    Publication date: January 24, 2019
    Inventors: Yuhong Xu, Meiqing Tu, Xiaojing Chen
  • LIPOSOME FORMULATION FOR DELIVERY OF WNT SIGNAL PATHWAY INHIBITOR
    Publication number: 20190022003
    Abstract: A liposome formulation for delivery of Wnt signal pathway inhibitor is provided herein, which comprises lipid molecules and Wnt signal pathway inhibitor, wherein the liposome formulation is prepared through following steps: (1) providing an aqueous solution of the Wnt signal pathway inhibitor and providing an alcoholic solution of the lipid molecules, (2) mixing the aqueous solution of the Wnt signal pathway inhibitor and the alcoholic solution of the lipid molecules, (3) removing alcohol solvent to obtain the liposome formulation with Wnt signal pathway inhibitor encapsulated therein.
    Type: Application
    Filed: April 3, 2018
    Publication date: January 24, 2019
    Inventors: Yuhong Xu, Meiqing Tu, Xiaojing Chen